REGENXBIO Inc. Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENXBIO Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENXBIO Inc. for November 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 3.76 | 716 | 2,692 | 65,784 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 12.74 | 6,250 | 79,625 | 0 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 18.85 | 6,250 | 117,813 | 0 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 22.00 | 4,687 | 103,114 | 0 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 49.45 | 883 | 43,664 | 7,292 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 49.45 | 1,721 | 85,103 | 8,175 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 65.03 | 18,786 | 1,221,654 | 0 | 18.8 K to 0 (-100.00 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 3.76 | 716 | 2,692 | 18,786 | 18.1 K to 18.8 K (+3.96 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 12.74 | 6,250 | 79,625 | 18,070 | 11.8 K to 18.1 K (+52.88 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 18.85 | 6,250 | 117,813 | 11,820 | 5.6 K to 11.8 K (+112.21 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 22.00 | 4,687 | 103,114 | 5,570 | 883 to 5.6 K (+530.80 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 49.45 | 883 | 43,664 | 883 | 0 to 883 | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 65.00 | 1,721 | 111,865 | 0 | 1.7 K to 0 (-100.00 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 49.45 | 1,721 | 85,103 | 1,721 | 0 to 1.7 K | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 64.64 | 8,620 | 557,197 | 251,000 | 259.6 K to 251 K (-3.32 %) |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 63.81 | 11,380 | 726,158 | 259,620 | 271 K to 259.6 K (-4.20 %) |
| Nov 26 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 61.92 | 6,898 | 427,124 | 271,000 | 277.9 K to 271 K (-2.48 %) |
| Nov 26 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 61.22 | 6,802 | 416,418 | 277,898 | 284.7 K to 277.9 K (-2.39 %) |
| Nov 26 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 60.09 | 1,300 | 78,117 | 284,700 | 286 K to 284.7 K (-0.45 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 3.76 | 13,500 | 50,760 | 66,500 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 12.74 | 2,988 | 38,067 | 6,250 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 22.00 | 4,688 | 103,136 | 4,687 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 12.74 | 3,262 | 41,558 | 9,238 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 18.85 | 6,250 | 117,813 | 6,250 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 49.45 | 2,604 | 128,768 | 9,896 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 60.38 | 21,176 | 1,278,607 | 0 | 21.2 K to 0 (-100.00 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 3.76 | 13,500 | 50,760 | 21,176 | 7.7 K to 21.2 K (+175.87 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 12.74 | 2,988 | 38,067 | 7,676 | 4.7 K to 7.7 K (+63.74 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 22.00 | 4,688 | 103,136 | 4,688 | 0 to 4.7 K | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 63.53 | 600 | 38,118 | 0 | 600 to 0 (-100.00 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 62.81 | 600 | 37,686 | 600 | 1.2 K to 600 (-50.00 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 60.26 | 10,916 | 657,798 | 1,200 | 12.1 K to 1.2 K (-90.10 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 12.74 | 3,262 | 41,558 | 12,116 | 8.9 K to 12.1 K (+36.84 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 18.85 | 6,250 | 117,813 | 8,854 | 2.6 K to 8.9 K (+240.02 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 49.45 | 2,604 | 128,768 | 2,604 | 0 to 2.6 K | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 20,414 | 17,352 | 61,244 | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 63.21 | 1,100 | 69,531 | 0 | 1.1 K to 0 (-100.00 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 61.55 | 800 | 49,240 | 1,100 | 1.9 K to 1.1 K (-42.11 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 60.25 | 4,361 | 262,750 | 1,900 | 6.3 K to 1.9 K (-69.65 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 59.61 | 9,092 | 541,974 | 6,261 | 15.4 K to 6.3 K (-59.22 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 58.37 | 2,300 | 134,251 | 15,353 | 17.7 K to 15.4 K (-13.03 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 57.08 | 2,761 | 157,598 | 17,653 | 20.4 K to 17.7 K (-13.53 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 20,414 | 17,352 | 20,414 | 0 to 20.4 K |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 32,882 | 723,404 | 76,101 | |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 64.71 | 15,494 | 1,002,617 | 39,500 | 55 K to 39.5 K (-28.17 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 63.64 | 6,505 | 413,978 | 54,994 | 61.5 K to 55 K (-10.58 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 62.79 | 6,883 | 432,184 | 61,499 | 68.4 K to 61.5 K (-10.07 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 61.91 | 4,000 | 247,640 | 68,382 | 72.4 K to 68.4 K (-5.53 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 32,882 | 723,404 | 72,382 | 39.5 K to 72.4 K (+83.25 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 64.10 | 100 | 6,410 | 129,783 | 129.9 K to 129.8 K (-0.08 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 63.05 | 700 | 44,135 | 129,883 | 130.6 K to 129.9 K (-0.54 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 62.23 | 2,042 | 127,074 | 130,583 | 132.6 K to 130.6 K (-1.54 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 60.40 | 588 | 35,515 | 132,625 | 133.2 K to 132.6 K (-0.44 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 59.06 | 1,900 | 112,214 | 133,213 | 135.1 K to 133.2 K (-1.41 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 58.46 | 2,170 | 126,858 | 135,113 | 137.3 K to 135.1 K (-1.58 %) |
| Nov 09 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 72.06 | 15,000 | 1,080,900 | 2,669 | 17.7 K to 2.7 K (-84.89 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 20,414 | 17,352 | 81,658 | |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 69.97 | 4,627 | 323,751 | 0 | 4.6 K to 0 (-100.00 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 69.54 | 3,854 | 268,007 | 4,627 | 8.5 K to 4.6 K (-45.44 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 68.22 | 3,700 | 252,414 | 8,481 | 12.2 K to 8.5 K (-30.38 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 67.14 | 4,820 | 323,615 | 12,181 | 17 K to 12.2 K (-28.35 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 66.26 | 3,413 | 226,145 | 17,001 | 20.4 K to 17 K (-16.72 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 20,414 | 17,352 | 20,414 | 0 to 20.4 K |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 69.92 | 4,709 | 329,253 | 306,000 | 310.7 K to 306 K (-1.52 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 69.47 | 3,340 | 232,030 | 310,709 | 314 K to 310.7 K (-1.06 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 68.27 | 3,635 | 248,161 | 314,049 | 317.7 K to 314 K (-1.14 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 67.16 | 4,816 | 323,443 | 317,684 | 322.5 K to 317.7 K (-1.49 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 66.29 | 3,500 | 232,015 | 322,500 | 326 K to 322.5 K (-1.07 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 19.50 | 20,833 | 406,244 | 29,167 | |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 13.09 | 32,908 | 430,766 | 32,374 | |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 13.09 | 9,718 | 127,209 | 65,282 | |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 3.76 | 9,959 | 37,446 | 20,041 | |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 70.26 | 53,741 | 3,775,843 | 137,283 | 191 K to 137.3 K (-28.13 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 19.50 | 20,833 | 406,244 | 191,024 | 170.2 K to 191 K (+12.24 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 13.09 | 32,908 | 430,766 | 170,191 | 137.3 K to 170.2 K (+23.97 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 70.04 | 19,677 | 1,378,177 | 137,283 | 157 K to 137.3 K (-12.54 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 13.09 | 9,718 | 127,209 | 156,960 | 147.2 K to 157 K (+6.60 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 3.76 | 9,959 | 37,446 | 147,242 | 137.3 K to 147.2 K (+7.25 %) |